Drugs Medical Pharma

Treeline Biosciences discloses $421 million financing in latest filings

HQ Team October 19, 2024: Stealth startup Treeline Biosciences has raised another $421 million, one of the biggest raises of the year in.

Read More
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the.

Read More
Climate Drugs Pharma

China boosts emergency food supply in response to climate events

HQ Team October 17, 2024: Extreme weather conditions and the increasing number of natural disaster events have forced China to take steps to.

Read More
Drugs Medical Pharma

USFDA puts on hold influenza, Covid-19 trial vaccines of Novavax

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the.

Read More
Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

Read More
Drugs Health Medical

Understanding dementia: signs and care strategies for loved ones

Alvina Miller October 15, 2024: Finding out that you or someone close to you might have dementia can be really upsetting. But learning.

Read More
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
Drugs Health Medical

Danish study reveals half of patients with sepsis die within two years

HQ Team October 15, 2024: Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. According to.

Read More
Drugs Health Medical

New CAR T-cell therapy offers hope for children with aggressive blood cancer

HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell.

Read More
Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

Read More